LifeVantage price target lowered to $12 from $30 at Lake Street

Lake Street analyst Ryan Meyers lowered the firm’s price target on LifeVantage (LFVN) to $12 from $30 and keeps a Buy rating on the shares after Q1 results that reflected a seasonally soft period and tougher year-over-year comparisons. The analyst, while taking over coverage, is trimming the firm’s price target to reflect a revised revenue outlook and slightly lower valuation multiple.